Search Results - "Hens, Marc"
-
1
A kit method for the high level synthesis of [ 211At]MABG
Published in Bioorganic & medicinal chemistry (15-05-2007)“…meta-[ 211At]Astatobenzylguanidine ([ 211At]MABG), an analogue of meta-iodobenzylguanidine (MIBG) labeled with the α-emitter 211At, targets the norepinephrine…”
Get full text
Journal Article -
2
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG
Published in Nuclear medicine and biology (01-08-2015)“…Radioiodinated meta-iodobenzylguanidine (MIBG), a norepinephrine transporter (NET) substrate, has been extensively used as an imaging agent to study the…”
Get full text
Journal Article -
3
Synthesis and evaluation of 4-[18 F]fluoropropoxy-3-iodobenzylguanidine ([18 F]FPOIBG): A novel18 F-labeled analogue of MIBG
Published in Nuclear medicine and biology (2015)“…Abstract Introduction Radioiodinated meta -iodobenzylguanidine (MIBG), a norepinephrine transporter (NET) substrate, has been extensively used as an imaging…”
Get full text
Journal Article -
4
Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands
Published in Nuclear medicine and biology (01-02-2009)“…The monoclonal antibody (mAb) L8A4, reactive with the epidermal growth factor receptor variant III (EGFRvIII), internalizes rapidly in glioma cells after…”
Get full text
Journal Article -
5
Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with 177Lu: in vitro comparison of acyclic and macrocyclic ligands
Published in Nuclear medicine and biology (01-02-2009)“…The monoclonal antibody (mAb) L8A4, reactive with the epidermal growth factor receptor variant III (EGFRvIII), internalizes rapidly in glioma cells after…”
Get full text
Journal Article -
6
Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with177 Lu: in vitro comparison of acyclic and macrocyclic ligands
Published in Nuclear medicine and biology (2009)“…Abstract Introduction The monoclonal antibody (mAb) L8A4, reactive with the epidermal growth factor receptor variant III (EGFRvIII), internalizes rapidly in…”
Get full text
Journal Article -
7
Anti-EGFRvIII monoclonal antibody armed with177 Lu: in vivo comparison of macrocyclic and acyclic ligands
Published in Nuclear medicine and biology (2010)“…Abstract Introduction Monoclonal antibody (mAb) L8A4 binds specifically to the epidermal growth factor receptor variant III (EGFRvIII) that is present on…”
Get full text
Journal Article -
8
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
Published in Nuclear medicine and biology (01-10-2010)“…Monoclonal antibody (mAb) L8A4 binds specifically to the epidermal growth factor receptor variant III (EGFRvIII) that is present on gliomas but not on normal…”
Get full text
Journal Article -
9
Antitenascin antibody 81C6 armed with177 Lu: in vivo comparison of macrocyclic and acyclic ligands
Published in Nuclear medicine and biology (2007)“…Abstract Introduction When labeled with iodine-131, the antitenascin monoclonal antibody (mAb) 81C6 has shown promise as a targeted radiotherapeutic in…”
Get full text
Journal Article -
10
Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands
Published in Nuclear medicine and biology (01-02-2007)“…When labeled with iodine-131, the antitenascin monoclonal antibody (mAb) 81C6 has shown promise as a targeted radiotherapeutic in patients with brain tumors…”
Get full text
Journal Article